Can nitrofurantoin (Macrobid) and amoxicillin‑clavulanate be taken together for a urinary tract infection while the patient is already taking nitrofurantoin daily?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Should You Take Macrobid and Amoxicillin-Clavulanate Together for UTI While on Daily Macrobid?

No, you should not take both antibiotics simultaneously—instead, stop the daily Macrobid prophylaxis and switch to amoxicillin-clavulanate alone for treatment of the acute UTI.

Clinical Reasoning

When a patient on daily nitrofurantoin prophylaxis develops a breakthrough UTI, this represents either:

  • Treatment failure of the prophylactic agent
  • Infection with a resistant organism
  • Possible tissue infection beyond the bladder

The 2024 European Association of Urology guidelines explicitly state that when symptoms do not resolve or recur, you should assume the infecting organism is not susceptible to the agent originally used, and retreatment with a 7-day regimen using another agent should be considered 1. This directly applies to your situation—the patient is already on nitrofurantoin, so adding more of the same drug makes no therapeutic sense.

Why Not Combine Them?

  • No synergistic benefit: There is no evidence that combining nitrofurantoin with amoxicillin-clavulanate provides additive or synergistic effects for UTI treatment
  • Increased adverse effects: Both drugs have gastrointestinal side effects; nitrofurantoin carries risks of pulmonary reactions and polyneuropathy with prolonged use 2, while amoxicillin-clavulanate commonly causes GI symptoms and candida vaginitis 3
  • Resistance concern: If the organism broke through nitrofurantoin prophylaxis, continuing it during acute treatment is illogical
  • No guideline support: No major guideline recommends dual therapy with these agents

Recommended Approach

  1. Obtain a urine culture before switching antibiotics 1—this is critical when symptoms occur during prophylaxis

  2. Stop the daily Macrobid prophylaxis temporarily

  3. Start amoxicillin-clavulanate as monotherapy for 7 days (standard duration for treatment when switching agents after failure) 1

  4. After completing treatment and confirming cure, reassess whether to:

    • Resume nitrofurantoin prophylaxis (if the culture shows the organism was susceptible to amoxicillin-clavulanate but not nitrofurantoin)
    • Switch to a different prophylactic strategy
    • Consider non-antimicrobial prevention methods 1

Important Caveats

  • If this is pyelonephritis or febrile UTI, neither nitrofurantoin nor amoxicillin-clavulanate may be optimal first-line choices. Nitrofurantoin specifically lacks broader tissue distribution and is indicated only for acute cystitis 4. Consider ceftriaxone or fluoroquinolones for upper tract infections 5.

  • Amoxicillin-clavulanate is not listed as first-line therapy in the 2024 EAU guidelines for uncomplicated cystitis 1, though it has demonstrated efficacy in older studies 6, 3. Its use should be guided by local resistance patterns.

  • The breakthrough UTI while on prophylaxis warrants investigation for underlying urological abnormalities if this becomes recurrent 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.